Results indicate that 12 months after carotid intervention the CGuard EPS MicroNET-covered stent delivers sustained protection against postprocedural neurologic events TEL AVIV, Israel, June 10, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid […]
Neuro
Cerus Endovascular Receives CE Mark Approval for its 021 Contour Neurovascular System™
Commercial Sales Across European Union Expected to Begin During Fourth Quarter of 2020 FREMONT, Calif. and OXFORD, England, April 29, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its 021 Contour Neurovascular System™, compatible with smaller commercially available 021 […]
Cerus Endovascular Receives CE Mark Approvals for its Neqstent™ Coil Assisted Flow Diverter Designed to Treat Intracranial Aneurysms
Commercial Sales Across European Union Expected to Begin During Fourth Quarter of 2020 FREMONT, Calif. and OXFORD, United Kingdom, April 22, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its Neqstent™ Coil Assisted Flow Diverter device, designed to treat […]
Rapid Medical Announces Ahead of Schedule Completion of Patient Enrollment for the TIGER Clinical Study for TIGERTRIEVER Thrombectomy Device
YOKNEAM, Israel, April 7, 2020 /PRNewswire/ — Rapid Medical, a company focused on the development of next generation neurovascular interventional devices, has announced that it has completed enrollment in the TIGER (Treatment with Intent to Generate Reperfusion) study ahead of the planned scheduled. This is a US based, multi-center study of the performance of TIGERTRIEVER, the company’s […]
Artio Medical Announces Interim Study Results Highlighting Aneurysm Occlusion Device at Neurovascular Conference
FAIRWAY, Kan., March 17, 2020 /PRNewswire/ — Artio Medical, a medical device company developing innovative products for peripheral vascular and neurovascular diseases, announced today the recent presentation of interim nonclinical study results at the ABC-WIN Seminar in Val d’Isere, France. Presented by Dr. Blaise Baxter, a neurovascular and peripheral interventional radiologist, the interim data demonstrated […]
Cerus Endovascular Successfully Completes Series B Financing and Receives U.S. FDA Approval for its First Microcatheter
Completion of Series B Financing Round Strengthens and Readies the Company for Commercialization of Two Products During the Second Quarter of 2020 FREMONT, Calif. and OXFORD, England, Feb. 21, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has now successfully completed its Series B financing having […]
Cerus Endovascular Receives CE Mark Approval for its Contour Neurovascular System™, Designed to Treat Intracranial Aneurysms
Commercial Sales Across European Union Expected to Begin in Second Quarter of 2020 FREMONT, Calif. and OXFORD, England, Feb. 18, 2020 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its lead product, the Contour Neurovascular System™, for the treatment of […]
RIST Neurovascular, Inc. Announces FDA Clearance of the First Catheter Specifically Designed to Access the Neurovasculature through the Radial Artery
RIST Cath device enables a radial approach during neurointerventional procedures for introduction of devices into the neurovasculature MIAMI BEACH, Fla.–(BUSINESS WIRE)–RIST Neurovascular, Inc., a neuro-interventional medtech company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the RIST Cath Radial Access Long Sheath™ (RIST […]
Metactive Medical Announces Name Change to Artio Medical
FAIRWAY, Kan., Feb. 11, 2020 /PRNewswire/ — Metactive Medical, Inc., a medical device company developing innovative products for peripheral vascular and neurovascular diseases, announced today that it has changed its name to Artio Medical, Inc. effective immediately. “The corporate name change marks an important milestone as we progress toward commercialization,” said F. Nicholas Franano, […]
ABBOTT ANNOUNCES FIRST-OF-ITS-KIND TRIAL TO ASSESS NEW THERAPY OPTION FOR PEOPLE AT RISK OF STROKE
– The CATALYST trial will examine Abbott’s Amplatzer™ Amulet™ device compared to non-vitamin K oral anticoagulants, the current standard in attempting to lower stroke and bleeding risks for patients with atrial fibrillation ABBOTT PARK, Ill., Feb. 3, 2020 /PRNewswire/ — Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration […]
Recent
Popular
- No commented posts yet